Lockhart, Michelle M.

A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease

Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A. J., Murphy, M. P., Taylor, K. M., & On behalf of the Protect Study Group (2010) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effects

Cited by 606

The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients: Mitoquinone and liver damage

Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International

Hepatitis C virus researchDrug-Induced Hepatotoxicity and Protection

Cited by 379

847 phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C

Gane, E. J., Orr, D. W., Weilert, F., Keogh, G. F., Gibson, M., Murphy, M. P., Smith, R. A., Lockhart, M. M., Frampton, C. M., & Taylor, K. M. (2008) · Journal of Hepatology

Hepatitis C virus researchCoenzyme Q10 studies and effects

Cited by 11